Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |
| Name of reporting entity or other means of identification |
Hyloris Pharmaceuticals SA
|
| Domicile of entity |
Belgium
|
| Legal form of entity |
limited liability company
|
| Address of entity's registered office |
Boulevard Patience et Beaujonc N°3/1, 4000 Liège,
|
| Description of nature of entity's operations and principal activities |
Hyloris is a specialty biopharma company identifying
|
| Name of parent entity |
Hyloris Pharmaceuticals SA
|
| Statement of IFRS compliance [text block] |
These consolidated financial statements of the Group
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
14
|